Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator

被引:3
|
作者
Hirano, T [1 ]
Mori, T [1 ]
Kido, M [1 ]
Toide, K [1 ]
Ohura, M [1 ]
Fujiki, H [1 ]
Orito, K [1 ]
Yoshida, K [1 ]
Ikezono, K [1 ]
Sumida, T [1 ]
Nakayama, N [1 ]
Yabuuchi, Y [1 ]
机构
[1] Otsuka Pharmaceut Co Ltd, Tokushima Inst New Drug Res 2, Tokushima 7710192, Japan
关键词
pranidipine; optical-isomers; calcium channel blocking action; isolated aorta; anaesthetized rat; structure-activity relationship; spontaneously hypertensive rats;
D O I
10.1111/j.1472-8206.1999.tb00376.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pranidipine is an optically-active 1,4-dihydropyridine (DHP) voltage-dependent L-type calcium channel inhibitor. Certain enantiomeric pairs display opposite effects, i.e., inhibition and activation of the calcium channel while others exhibit the same qualitative actions. We investigated pranidipine, a new DHP, using a paradigm of vascular smooth muscle reactivity. In isolated rat aorta, depolarized with 80 mM KCl, both isomers of pranidipine caused a right-ward shift of the concentration-contraction curves for extracellular Ca2+. The apparent pA(2) values of the S-isomer and R-isomer were 10.03 and 8.36, respectively, providing evidence that the calcium channel blocking action of the S-isomer was 50 times more potent than that of the R-isomer. Antihypertensive actions of these two isomers studied in pentobarbital-anaesthetized spontaneously hypertensive rats, revealed that the S-isomer, at doses of 3-30 mu g/kg i.v. decreased blood pressure in a dose-dependent manner, while the R-isomer had no effect on blood pressure at those doses. We conclude that the pair of enantiomers of pranidipine qualitatively display the same Ca2+ channel blocking action and that neither isomer exhibits Bay K 8644-like activation. Pranidipine may be useful in studies on the architecture of the DHP receptor 'pocket'. (C) 1999 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:650 / 655
页数:6
相关论文
共 50 条
  • [31] THE INTERACTION OF PHENYLALKYLAMINE CALCIUM-CHANNEL BLOCKERS WITH THE 1,4-DIHYDROPYRIDINE BINDING-SITE
    ZOBRIST, RH
    GIACOMINI, KM
    NELSON, WL
    GIACOMINI, JC
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1986, 18 (09) : 963 - 974
  • [32] QSAR study of 1,4-dihydropyridine calcium channel antagonists based on gene expression programming
    Si, Hong Zong
    Wang, Tao
    Zhang, Ke Jun
    Hu, Zhi De
    Fan, Bo Tao
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (14) : 4834 - 4841
  • [33] RECEPTOR-BINDING PROPERTIES OF KW-3049, A NEW 1,4-DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKER
    ISHII, A
    NISHIDA, K
    OKA, T
    NAKAMIZO, N
    JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P96 - P96
  • [35] ANALYSIS OF THE EFFECTS OF (-) AND (+) ISOMERS OF THE 1,4-DIHYDROPYRIDINE CALCIUM-CHANNEL AGONIST BAY K 8644 ON POSTREST POTENTIATION IN THE CANINE VENTRICULAR MUSCLE
    SAHA, JK
    HRYSHKO, LV
    BOUCHARD, RA
    CHAU, T
    BOSE, D
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (07) : 788 - 794
  • [36] Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents
    Amini, M
    Golabchifar, AA
    Dehpour, AR
    Pirali, HM
    Shafiee, A
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2002, 52 (01): : 21 - 26
  • [37] 1,4-DIHYDROPYRIDINE ANTAGONIST ACTIVITIES AT THE CALCIUM-CHANNEL - A QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP APPROACH
    COBURN, RA
    WIERZBA, M
    SUTO, MJ
    SOLO, AJ
    TRIGGLE, AM
    TRIGGLE, DJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (11) : 2103 - 2107
  • [38] Mechanochemical enzymatic synthesis of 1,4-dihydropyridine calcium antagonists and derivatives
    Jiang, Ling
    Ye, Li-dan
    Gu, Jia-li
    Su, Wei-ke
    Ye, Wen-ting
    JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2019, 94 (08) : 2555 - 2560
  • [39] Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities
    Aydin, F.
    Safak, C.
    Simsek, R.
    Erol, K.
    Ulgen, M.
    Linden, A.
    PHARMAZIE, 2006, 61 (08): : 655 - 659
  • [40] 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety
    Budriesi, R
    Bisi, A
    Ioan, P
    Rampa, A
    Gobbi, S
    Belluti, F
    Piazzi, L
    Valenti, P
    Chiarini, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (10) : 3423 - 3430